ABIONYX Pharma SA (ABNX.PA)
EUR 1.25
(2.46%)
EUR 1.25
(2.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.64 Million | 5.25 Million | 675 Thousand | - | - | 174 Thousand |
| Cost of Revenue | 4.02 Million | 4.61 Million | 416 Thousand | 80 Thousand | 72 Thousand | - |
| Gross Profit | 618 Thousand | 636 Thousand | 259 Thousand | -80 Thousand | -72 Thousand | 174 Thousand |
| Operating Expenses | 4.17 Million | 4.74 Million | 6.21 Million | 2.96 Million | 2.52 Million | 7.22 Million |
| Selling, General and Administrative Expenses | 1.1 Million | 1.32 Million | 586 Thousand | 562 Thousand | 1.12 Million | 1.19 Million |
| Research and Development Expenses | 2.9 Million | 1.1 Million | 4.92 Million | 1.69 Million | 744 Thousand | 4.29 Million |
| Other Expenses | - | 2.31 Million | 697 Thousand | 708 Thousand | 655 Thousand | 1.74 Million |
| Cost and Expenses | 8.19 Million | 9.36 Million | 6.62 Million | 2.96 Million | 2.52 Million | 7.22 Million |
| Operating Income | -3.41 Million | -4.1 Million | -5.95 Million | -2.96 Million | 2.23 Million | -7.05 Million |
| Interest Expense | 19 Thousand | 61 Thousand | 8000.00 | 95 Thousand | 350 Thousand | - |
| Income Tax Expense | - | 97 Thousand | 8000.00 | -617 Thousand | 38 Thousand | 1000.00 |
| Earnings before Tax | -3.51 Million | -4.2 Million | -5.82 Million | -1.88 Million | 1.88 Million | -6.3 Million |
| Net Income | -3.51 Million | -4.3 Million | -5.83 Million | -1.88 Million | 1.84 Million | -6.3 Million |
| Earnings Per Share Basic | -0.12 | -0.15 | -0.23 | -0.08 | 0.09 | -0.32 |
| Earnings Per Share Diluted | -0.12 | -0.15 | -0.23 | -0.08 | 0.09 | -0.32 |
| Weighted Average Shares Outstanding | 29.34 Million | 27.96 Million | 24.87 Million | 22.5 Million | 20.59 Million | 19.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.34 Million | 27.96 Million | 24.87 Million | 22.5 Million | 21.12 Million | 19.62 Million |
| Gross Margin | 0.13 | 0.12 | 0.38 | - | - | 1.00 |
| EBIT Margin | -0.71 | -0.76 | -8.44 | - | - | -31.89 |
| Profit Margin | -0.76 | -0.82 | -8.64 | - | - | -36.24 |
| EBITDA | -3.29 Million | -3.98 Million | -5.83 Million | -2.32 Million | 1.8 Million | -6.26 Million |
| Earnings Before Tax Margin | -0.74 | -0.78 | -8.82 | - | - | -40.53 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 2.34 Million | 4.64 Million | 1.25 Million | 1.25 Million | 2.12 Million | 1.06 Million |
| Cost of Revenue | 2.06 Million | 3.49 Million | 941.5 Thousand | 941.5 Thousand | 2.15 Million | 1.06 Million |
| Gross Profit | 275 Thousand | 1.14 Million | 314.5 Thousand | 314.5 Thousand | -30 Thousand | -5500.00 |
| Operating Expenses | 2.86 Million | 6.03 Million | 972 Thousand | 972 Thousand | 2.89 Million | 1.11 Million |
| Selling, General and Administrative Expenses | 1.55 Million | - | 572.5 Thousand | 572.5 Thousand | 1.44 Million | 732 Thousand |
| Research and Development Expenses | 1.31 Million | - | 1.07 Million | 1.07 Million | 1.44 Million | 379.5 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 4.93 Million | 9.53 Million | 1.91 Million | 1.91 Million | 5.05 Million | 2.18 Million |
| Operating Income | -2.58 Million | -4.89 Million | -592 Thousand | -592 Thousand | -2.92 Million | -1.11 Million |
| Interest Expense | 42 Thousand | 19 Thousand | 220 Thousand | - | 80 Thousand | - |
| Income Tax Expense | -450 Thousand | -1.38 Million | -694 Thousand | - | -690 Thousand | - |
| Earnings before Tax | -2.53 Million | -4.9 Million | -635 Thousand | -635 Thousand | -2.93 Million | -1.12 Million |
| Net Income | -2.08 Million | -3.51 Million | -635 Thousand | -635 Thousand | -2.24 Million | -1.12 Million |
| Earnings Per Share Basic | -0.06 | - | -0.02 | -0.02 | -0.08 | -0.04 |
| Earnings Per Share Diluted | -0.06 | - | -0.02 | -0.02 | -0.08 | -0.04 |
| Weighted Average Shares Outstanding | 32.2 Million | 29.34 Million | 30.11 Million | 30.11 Million | 28.41 Million | 28.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 32.2 Million | 29.34 Million | 30.28 Million | 30.28 Million | 28.41 Million | 28.41 Million |
| Gross Margin | 0.12 | 0.25 | 0.25 | 0.25 | -0.01 | -0.01 |
| EBIT Margin | -0.98 | - | -0.45 | -0.44 | -1.25 | -1.01 |
| Profit Margin | -0.89 | -0.76 | -0.51 | -0.51 | -1.06 | -1.06 |
| EBITDA | -2.29 Million | - | -561.5 Thousand | -554.5 Thousand | -2.66 Million | -1.07 Million |
| Earnings Before Tax Margin | -1.10 | -1.05 | -0.47 | -0.47 | -1.37 | -1.05 |
FHB
MLONL
603690
WSSTF
NCTKY
002349